Sinobiopharma, Inc. (fka SNBP)

[Florinda]

Bullnovice,

Thanks for that link. The dramatic increase in revenue is great. Is anyone worried that this is essentially a one trick pony? Cisatracurium Besylate constitued 98.5% of their revenue! Also, I Googled this drug and it said "Cisatracurium Besylate’s innovator is GlaxoSmithKline-HQ-Europe and is marketed world-wide by the brand names: Nimbex® and Nombexir"

http://www.tapi.com/tapiteva/productPages/Cisatracurium_Besylate

I'd hate to have such a huge company as GlaxoSmithKline as a competitor. Likewise, I would have thought if SNBP invented a unique drug they would not have named it and spelled it exactly the same as GlaxoSmithKline's. Presumably I'm missing something fundamental here. But it did give me pause. Can you shed some light on the matter?

Thanks,

Steve